Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...

C3G and IC-MPGN can be difficult to diagnose because they are so rare and their symptoms are vague and nonspecific. A kidney biopsy is considered the gold standard and usually needed to confirm the ...

EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...

Certainly, cravings can get the best of us and in some cases too much of what we crave can result in some unhealthy outcomes.

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

NAB believes that with GPS increasingly recognized as a potential single point of failure, BPS has an important role to play.

Your home is a treasure chest of items that, with a little creativity, can find a new purpose in your backyard. Before you ...

Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands.

As enterprises race to deploy autonomous AI agents, a growing concern has emerged around what these agents are permitted to ...